Added to YB: 2019-09-04
Pitch date: 2019-09-04
HEMA:US [bullish]
HemaCare Corporation
+51.1%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States.
Market Cap
$346.5M
Pitch Price
$16.75
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
50.39
EV/Sales
N/A
Sector
Health Care Providers and Services
Category
N/A
Show full summary:
HEMACARE CORP HEMA:US
A summary for this pitch has not been created yet.
Read full article (0 min)